Benitec Biopharma
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Benitec Biopharma's past years’ income statements indicate that its last revenue has increased compared to the previous period by 188% to $216,000. Profit margin reached -10070%. Total operating expenses were $22,382,000.
Profit Margin
| 2015 | 829.12K | -8.82M | -1064.66% |
|---|---|---|---|
| 2016 | 346.50K | -18.50M | -5340.09% |
| 2017 | 450.31K | -4.37M | -970.99% |
| 2018 | 455.44K | -8.55M | -1877.42% |
| 2019 | 11.31M | 2.86M | 25.34% |
| 2020 | 97K | -8.30M | -8557.73% |
| 2021 | 59K | -13.78M | -23357.63% |
| 2022 | 73K | -18.56M | -25427.4% |
| 2023 | 75K | -19.56M | -26082.67% |
| 2024 | 216K | -21.75M | -10069.91% |
BNTC Income Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 216K | 75K | 73K | 59K | 97K | 11.31M | 455.44K | 450.31K | 346.50K | 829.12K |
Cost of revenue | 108K | 381K | 9K | 123K | 268.06K | 426.50K | 331.3K | 209.01K | 103.80K | 30.68K |
Gross profit | 108K | -306K | 64K | -64K | -171.06K | 10.89M | 124.14K | 241.29K | 242.70K | 798.44K |
Operating exp. | ||||||||||
Research and development | 15.60M | 12.77M | 11.27M | 7.02M | 3.00M | 2.17M | 5.06M | 5.32M | 9.92M | 4.77M |
Selling and marketing | 277K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 22.38M | 19.15M | 17.91M | 13.53M | 8.56M | 8.98M | 8.67M | 4.40M | 16.20M | 8.80M |
Operating income | -22.49M | -19.08M | -17.85M | -13.59M | -8.28M | 2.00M | -8.55M | -15.92M | -24.96M | -13.32M |
Other income (expenses), net | 120K | -481K | -354K | -286K | 7K | 864.21K | 1.46K | 11.55M | -2.54M | 4.50M |
Income before tax | -22.37M | -19.56M | -18.20M | -13.88M | -8.27M | 2.86M | -8.55M | -4.37M | -18.50M | -8.82M |
Income tax expense | -619K | 3K | 354K | -101K | 27K | -864.21K | 1.46K | 209.78K | -9.00M | 821.45K |
Net income | -21.75M | -19.56M | -18.56M | -13.78M | -8.30M | 2.86M | -8.55M | -4.37M | -18.50M | -8.82M |
Earnings per share | ||||||||||
Basic EPS | -5.36 | -14.12 | -38.62 | -54.54 | -138.19 | 56.89 | -207.21 | -127.11 | -887.97 | -389.77 |
Diluted EPS | -5.36 | -14.12 | -38.62 | -54.54 | -138.19 | 56.89 | -207.21 | -127.11 | -887.97 | -389.77 |
| Data source | Data source | Data source | Data source | Data source |